GSK and Vir Biotechnology Expand Monoclonal Antibody Partnership

By Sam | February 17, 2021

GlaxoSmithKline (GSK) and Vir Biotechnology have teamed up to develop monoclonal antibodies for respiratory viruses, building off an existing agreement struck last year to develop COVID-19 therapies.
Source: Drug Industry Daily

Posted in Drug Industry Daily